Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review-Reference-Cited by-同舟云学术

Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review

Published:2023-11-08 Issue: Volume: Page:
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Zúñiga D.,Stumpf M. A. M.^ORCID,Monteiro A. L. S.^ORCID,Glezer A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s40618-023-02231-z.pdf

Reference37 articles.

1. Wong A, Eloy JA, Couldwell WT, Liu JK (2015) Update on prolactinomas. Part 1: clinical manifestations and diagnostic challenges. J Clin Neurosci Off J Neurosurg Soc Aust 22(10):1562–1567. https://doi.org/10.1016/j.jocn.2015.03.058

2. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82(7):2102–2107. https://doi.org/10.1210/jcem.82.7.4088

3. Tirosh A, Benbassat C, Lifshitz A, Shimon I (2015) Hypopituitarism patterns and prevalence among men with macroprolactinomas. Pituitary 18(1):108–115. https://doi.org/10.1007/s11102-014-0563-z

4. Behan LA, Draman MS, Moran C et al (2011) Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review. Pituitary 14(4):362–366. https://doi.org/10.1007/s11102-009-0168-0

5. Maiter D (2019) Management of dopamine agonist-resistant prolactinoma. Neuroendocrinology 109(1):42–50. https://doi.org/10.1159/000495775

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letrozole/Temozolomide/Testosterone;Reactions Weekly;2024-06-22

2. Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism;Endocrine;2024-04-05

3. Correction: Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review;Journal of Endocrinological Investigation;2023-12-11